EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden

Minji K Lee iD, Sandra A Mitchell iD, Ethan Basch, Allison M Deal iD, Blake T Langlais, Gita Thanarajasingam, Brenda F Ginos, Lauren Rogak iD, Tito R Mendoza, Antonia V Bennett iD, Brie N Noble, Gina L Mazza iD und 1 weitere

Cancers · 28.10.2025 · 17 (21) · 3459

DOI: 10.3390/cancers17213459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 28.10.2025. Verfasst von Minji K Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, CCR NIH HHS, US National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The PRO-CTCAE provides patient-reported data on symptomatic AEs. A summary metric—the ACS—reflecting total AE burden can be calculated by averaging AE-level composite scores at a given timepoint for each participant. This study investigated the psychometric properties and interpretability of this PRO-CTCAE ACS in patients with breast, lung, or head/neck cancers.

Methods

We conducted a secondary analysis of a PRO-CTCAE validation dataset comprising 940 adults undergoing chemotherapy or radiation therapy (clinicaltrials.gov: NCT02158637). We focused on empirically recommended symptom terms for three cancer sites. Analyses included Spearman’s correlations, coefficient alpha, and eigenvalues from the correlation matrices, confirmatory factor analysis (CFA), and principal component analysis (PCA). Latent profile analysis (LPA) was used to assess ACS interpretability in the lung cohort.

Results

Mean composite score inter-correlations were moderate (0.30–0.35), and coefficient alphas were high (0.81–0.91). Eigenvalue ratios and CFA supported retention of a single factor/component, with suitable model fit indices. ACS correlated highly with factor scores and the first principal component from the PCA. Reduced sets of terms produced reliable scores that closely approximated the full set scores and aligned with external criteria. LPA in the lung subgroup identified four latent classes; ACS differentiated high vs. low symptom burden groups but did not distinguish the two groups expressing distinct symptom profiles.

Conclusion

The ACS demonstrated structural validity through adequately fitting linear factor models and effectively summarized symptomatic AE burden. However, similar ACS values may mask clinically distinct symptomatic AE profiles, underscoring the value of both summary metrics and profile-based approaches.

Schlagwörter

Stichwörter der Autor:innen

ACSoverall symptomatic adverse event burdenpsychometric validationtotal adverse event burden

Autor:innen und Institutionen

  • Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
  • Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD 20850, USA.
  • University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.
  • Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ 85259, USA.
  • Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
  • Center for Cancer Research, National Cancer Institute, Rockville, MD 20850, USA.

ORCID-Profile: Minji K Lee, Sandra A Mitchell, Allison M Deal, Lauren Rogak, Antonia V Bennett, Gina L Mazza, Amylou C Dueck

Förderung

  • NCI NIH HHS
  • CCR NIH HHS
  • US National Cancer Institute

Zitieren

APA

Lee, M. K., Mitchell, S. A., Basch, E., Deal, A. M., Langlais, B. T., Thanarajasingam, G., Ginos, B. F., Rogak, L., Mendoza, T. R., Bennett, A. V., Noble, B. N., Mazza, G. L., & Dueck, A. C. (2025). Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden. Cancers, 17(21), 3459. https://doi.org/10.3390/cancers17213459

Vancouver

Lee MK, Mitchell SA, Basch E, Deal AM, Langlais BT, Thanarajasingam G, et al. Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden. Cancers. 2025;17(21):3459. doi:10.3390/cancers17213459

BibTeX
@article{Lee2025,
  author = {Lee, Minji K and Mitchell, Sandra A and Basch, Ethan and Deal, Allison M and Langlais, Blake T and Thanarajasingam, Gita and Ginos, Brenda F and Rogak, Lauren and Mendoza, Tito R and Bennett, Antonia V and Noble, Brie N and Mazza, Gina L and Dueck, Amylou C},
  title = {Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {21},
  pages = {3459},
  doi = {10.3390/cancers17213459}
}
Kostenlos starten →